Literature DB >> 6028624

The intraocular penetration of ampicillin, methicillin, and oxacillin.

R E Records, P P Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6028624     DOI： 10.1016/0002-9394(67)93354-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  7 in total

1.  Ciprofloxacin concentration in the rabbit aqueous humor and vitreous following intravenous and subconjunctival administration.

Authors:  W Behrens-Baumann; J Martell
Journal:  Infection       Date:  1988       Impact factor: 3.553

2.  Aqueous humor assays of subconjunctival antibiotics.

Authors:  S D McPherson; G D Presley; J R Crawford
Journal:  Trans Am Ophthalmol Soc       Date:  1968

3.  Intravitreal oxacillin in experimental staphylococcal endophthalmitis.

Authors:  R T Kasbeer; G A Peyman
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-09-05

4.  Azlocillin concentrations in human aqueous humor after intravenous and subconjunctival administration.

Authors:  W Behrens-Baumann; R Ansorg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

5.  Intravenous treatment of experimental Staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime and amikacin.

Authors:  Michael Engelbert; Herminia Miño de Kaspar; Martina Mette; Martin Thiel; Christopher N Ta; Thomas Grasbon; Markus Schulze-Schwering; Volker Klauss; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-14       Impact factor: 3.117

6.  Intravitreal penetration of oral pefloxacin in humans.

Authors:  M Oncel; G A Peyman
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

7.  Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.

Authors:  Michael Engelbert; Herminia Miño de Kaspar; Martin Thiel; Thomas Grasbon; Christopher N Ta; Markus Schulze-Schwering; Volker Klauss; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-24       Impact factor: 3.117
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.